EyeGate Pharmaceuticals vs Sylentis
EyeGate Pharmaceuticals vs Sylentis, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyeGate Pharmaceuticals is on 32/100 and Sylentis on 55/100.
Where each one leads
EyeGate Pharmaceuticals
- agent readiness: 39/100 against 32/100
- domain rating: 34/100 against 22/100
Sylentis
- our overall score: 55/100 against 32/100
- funding raised: $135M against $45.5M
At a glance
| Measure | EyeGate Pharmaceuticals | Sylentis |
|---|---|---|
| What it is | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. | Ophthalmic pharmaceutical company developing novel treatments for ocular diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2C | B2B2C | B2G | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2000 | 2000 |
| Headquarters | Waltham, United States | Madrid, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | EyeGate Pharmaceuticals | Sylentis |
|---|---|---|
| Employees | Not published | 61 |
| Total funding | $45.5M | $135M |
| Latest round | Debt | Series C |
| LinkedIn followers | Not published | 8,399 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyeGate Pharmaceuticals | Sylentis |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 32/100 | 55/100 |
| Traction | 38/100 | 58/100 |
| Team | 30/100 | 20/100 |
| Search visibility | 5/100 | 25/100 |
| Quality | 35/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 22/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyeGate Pharmaceuticals | Sylentis |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
EyeGate Pharmaceuticals vs Sylentis: common questions
Which is better, EyeGate Pharmaceuticals or Sylentis?
On our 0-100 score Sylentis rates higher (55/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do EyeGate Pharmaceuticals and Sylentis compare on the numbers?
EyeGate Pharmaceuticals leads on agent readiness (39/100 against 32/100), domain rating (34/100 against 22/100). Sylentis leads on our overall score (55/100 against 32/100), funding raised ($135M against $45.5M).
Read the full EyeGate Pharmaceuticals review and pricing or the Sylentis review and pricing. You can also browse other EyeGate Pharmaceuticals alternatives we track.